Bone metastases from poorly differentiated adenocarcinoma of the prostate diagnosed by In-111 ProstaScint (Capromab Pendetide) images with negative results of Tc-99m MDP bone scan and without significant elevation of prostate-specific antigen

Clin Nucl Med. 1999 Nov;24(11):905-7. doi: 10.1097/00003072-199911000-00025.

Authors

S Norris¹, R Halkar, J Galt, J Petros, J Keller

Affiliation

¹ Department of Radiology, Emory University Hospital, Atlanta, Georgia 30322, USA.

PMID: 10551485
DOI: 10.1097/00003072-199911000-00025

No abstract available

Publication types

Case Reports

MeSH terms

Adenocarcinoma / diagnostic imaging*
Adenocarcinoma / secondary*
Antibodies, Monoclonal*
Bone Neoplasms / diagnostic imaging*
Bone Neoplasms / secondary*
Humans
Indium Radioisotopes*
Male
Middle Aged
Prostate-Specific Antigen / blood
Prostatic Neoplasms / pathology
Radiopharmaceuticals
Technetium Tc 99m Medronate*
Tomography, Emission-Computed, Single-Photon

Substances

Antibodies, Monoclonal
Indium Radioisotopes
Radiopharmaceuticals
Capromab Pendetide
Prostate-Specific Antigen
Technetium Tc 99m Medronate